|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Merck & Co., Inc. (MRK) Announces Changes To Management Committee
10/19/2005 5:09:03 PM
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--July 29, 2005--Merck & Co., Inc. today announced changes in the responsibilities of several Management Committee members.
"These changes are designed to ensure an effective succession within the Merck Vaccines Division (MVD), consolidate senior leadership positions within U.S. Human Health (USHH) and create a new focus for Company-wide strategic planning," said Richard T. Clark, Chief Executive Officer and President, Merck.
Effective Sept. 1, Adel A.F. Mahmoud, M.D., Ph.D., President of Merck Vaccines, will assume the new Management Committee position of Chief Medical Advisor, Vaccines and Infectious Diseases. Dr. Mahmoud, who is scheduled for mandatory retirement from Merck in September 2006, will continue to report to Mr. Clark. Dr. Mahmoud will represent Merck in external medical, policy and government forums on matters of infectious diseases and vaccines.
|
|
|
|
|
|
|
|
|
|
|